EviCore updates its insurance coverage guidelines to reimburse AI software for analyzing coronary CT angiography (CCTA) images.
Key Details
- 1EviCore now recommends reimbursement for AI-based CCTA analysis from Cleerly, Heartflow, and Elucid.
- 2Guidelines apply to acute or stable chest pain patients and those with noted coronary stenoses.
- 3Policy takes effect October 1, 2024.
- 4Follows Medicare's recent approval and expanded payment for AI-backed CCTA analyses, now covering over 70% of Medicare patients.
- 5CMS doubled hospital/outpatient reimbursement for cardiac CT scans to $357.13 as of January 2024.
Why It Matters
Expanded payer coverage accelerates the clinical adoption of AI-powered CCTA, increasing access and incentives for hospitals to implement these advanced tools, which can aid early detection and personalized treatment for cardiac patients.
Source
Radiology Business
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.
•AuntMinnie
Deep Learning Models Rival Radiologists for Pancreatic Cancer Detection on CT
Deep-learning models achieved comparable or superior accuracy to experienced radiologists in detecting pancreatic cancer on CT scans, especially for small tumors.